journal article·2020-11

Switch from Polymorphic to Homogenous Self‐Assembly of Virus‐Like Particles of Simian Virus 40 through Double‐Cysteine Substitution

Chengchen Xu, Weiwei Zhu, Hanjing Mao, Wenjing Zhang, Gen‐Quan Yin, Xian‐En Zhang, Feng Li

Small· Volume 16· Issue 45
Publisher page

Abstract

Abstract Self‐assembled virus‐like particles (VLPs) hold great potential as natural nanomaterials for applications in many fields. For such purposes, monodisperse size distribution is a desirable property. However, the VLPs of simian virus 40 (SV40), a representative VLP platform, are characterized by polymorphism. In an attempt to eliminate the polymorphism, 15 mutants of the VLP subunit (VP1) are constructed through the substitution of double cysteines at the VP1 pentamer interfaces, generating a group of VLPs with altered size distributions. One of the mutants, SS2 (L102C/P300C), specifically forms homogenous T = 1‐like tiny VLPs of 24 ± 3 nm in diameter. Moreover, the stability of the SS2 VLPs is markedly enhanced compared with that of wild‐type VLPs. The homogeneous self‐assembly and stability enhancement of SS2 VLPs can be attributed to the new disulfide bonds contributed by Cys102 and Cys300, which are identified by mass spectrometry and explored by molecular dynamics simulations. Endocytosis inhibition assays indicate that SS2 VLPs, like the polymorphic wild‐type VLPs, preserve the multipathway feature of cellular uptake. SS2 VLPs may serve as an evolved version of SV40 VLPs in future studies and applications. The findings of this work would be useful for the design and fabrication of VLP‐based materials and devices.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bacteriophages and microbial interactions · Polyomavirus and related diseases · Plant Virus Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangzhou Women and Children's Medical Center Guangzhou Medical University Guangzhou 510623 P. R. China

State Key Laboratory of Virology Wuhan Institute of Virology Center for Biosafety Mega‐Science Chinese Academy of Sciences (CAS) Wuhan 430071 P. R. China

College of Life Science University of Chinese Academy of Sciences Beijing 100049 P. R. China

National Laboratory of Biomacromolecules CAS Center for Excellence in Biomacromolecules Institute of Biophysics Chinese Academy of Sciences (CAS) Beijing 100101 P. R. China

Funding

National Natural Science Foundation of China · National Basic Research Program of China

References (62)

Show source-provided references
1. 10.1126/science.112322310.1126/science.1123223 ↗
2. 10.1002/smll.20130139310.1002/smll.201301393 ↗
3. 10.1039/C5CS00287G10.1039/C5CS00287G ↗
4. 10.1007/s12274-017-1541-310.1007/s12274-017-1541-3 ↗
5. 10.1002/smll.20140151210.1002/smll.201401512 ↗
6. 10.1038/3021110.1038/30211 ↗
7. 10.1021/acs.chemrev.6b0022810.1021/acs.chemrev.6b00228 ↗
8. 10.1021/jacs.8b0391410.1021/jacs.8b03914 ↗
9. 10.1038/nnano.2012.22010.1038/nnano.2012.220 ↗
10. 10.1021/jacs.9b1377310.1021/jacs.9b13773 ↗
11. 10.7150/ntno.2138410.7150/ntno.21384 ↗
12. 10.1038/nchem.241610.1038/nchem.2416 ↗
13. 10.1038/nnano.2007.29910.1038/nnano.2007.299 ↗
14. 10.1021/acscatal.6b0010610.1021/acscatal.6b00106 ↗
15. 10.1021/acs.langmuir.8b0333710.1021/acs.langmuir.8b03337 ↗
16. 10.1016/j.coviro.2016.03.00110.1016/j.coviro.2016.03.001 ↗
17. Bao Q. · Adv. Drug Delivery Rev. · 2018 · 145 · 4010.1016/j.addr.2018.12.013 ↗
18. 10.1038/nnano.2015.29210.1038/nnano.2015.292 ↗
19. 10.1002/wnan.158710.1002/wnan.1587 ↗
20. 10.1016/S0969-2126(96)00019-610.1016/S0969-2126(96)00019-6 ↗
21. 10.1038/354278a010.1038/354278a0 ↗
22. 10.1128/JVI.75.1.61-72.200110.1128/JVI.75.1.61-72.2001 ↗
23. 10.1128/JVI.05753-1110.1128/JVI.05753-11 ↗
24. 10.1016/S0006-3495(89)82735-310.1016/S0006-3495(89)82735-3 ↗
25. 10.1099/vir.0.19067-010.1099/vir.0.19067-0 ↗
26. 10.1073/pnas.183224510010.1073/pnas.1832245100 ↗
27. 10.1371/journal.pone.000076510.1371/journal.pone.0000765 ↗
28. 10.1021/cb400551810.1021/cb4005518 ↗
29. Rosmalen M. G. M. · Sci. Adv. · 2020 · 6 · eaaz163910.1126/sciadv.aaz1639 ↗
30. 10.1021/ja211070310.1021/ja2110703 ↗
31. 10.1002/anie.20100743310.1002/anie.201007433 ↗
32. 10.1002/biot.20170061910.1002/biot.201700619 ↗
33. 10.1073/pnas.91.16.773210.1073/pnas.91.16.7732 ↗
34. 10.1006/viro.1999.018010.1006/viro.1999.0180 ↗
35. 10.1016/S0969-2126(00)00181-710.1016/S0969-2126(00)00181-7 ↗
36. 10.1016/S0969-2126(96)00020-210.1016/S0969-2126(96)00020-2 ↗
37. 10.1016/0092-8674(86)90071-110.1016/0092-8674(86)90071-1 ↗
38. 10.1021/cr040439010.1021/cr0404390 ↗
39. Secundo F. · Biotechnol. Bioeng. · 2010 · 108 · 49110.1002/bit.22963 ↗
40. 10.1080/07391102.2015.110955410.1080/07391102.2015.1109554 ↗
41. 10.3390/v1110091710.3390/v11100917 ↗
42. 10.1091/mbc.7.11.182510.1091/mbc.7.11.1825 ↗
43. 10.1002/smll.20080130310.1002/smll.200801303 ↗
44. 10.1128/JVI.02179-1010.1128/JVI.02179-10 ↗
45. 10.1016/j.cell.2004.09.00310.1016/j.cell.2004.09.003 ↗
46. 10.1016/j.virol.2016.05.02510.1016/j.virol.2016.05.025 ↗
47. 10.1021/acs.accounts.5b0035010.1021/acs.accounts.5b00350 ↗
48. 10.1021/jp807976510.1021/jp8079765 ↗
49. 10.1016/j.biochi.2011.12.00610.1016/j.biochi.2011.12.006 ↗
50. 10.1016/j.jmb.2015.06.01910.1016/j.jmb.2015.06.019 ↗
51. 10.7554/eLife.3147310.7554/eLife.31473 ↗
52. 10.1016/j.bbagen.2015.08.01710.1016/j.bbagen.2015.08.017 ↗
53. 10.1529/biophysj.105.07260310.1529/biophysj.105.072603 ↗
54. 10.1186/1471-2105-14-34610.1186/1471-2105-14-346 ↗
55. 10.1002/smll.20130086010.1002/smll.201300860 ↗
56. Laue T. M. · 1992 · 90
57. 10.1016/S0006-3495(00)76713-010.1016/S0006-3495(00)76713-0 ↗
58. 10.1038/nmeth.209910.1038/nmeth.2099 ↗
59. 10.1038/nmeth.328310.1038/nmeth.3283 ↗
60. 10.1093/nar/gky42710.1093/nar/gky427 ↗
61. 10.1021/acs.jctc.5b0025510.1021/acs.jctc.5b00255 ↗
62. Case D. A. · 2018